Stoke Therapeutics, Inc.STOKNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+20.8%
5Y CAGR+33.6%
Year-over-Year Change
Research and development spending
3Y CAGR
+20.8%/yr
vs +74.6%/yr prior
5Y CAGR
+33.6%/yr
Recent deceleration
Acceleration
-53.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $137.07M | +53.8% |
| 2024 | $89.13M | +8.4% |
| 2023 | $82.23M | +5.6% |
| 2022 | $77.84M | +43.7% |
| 2021 | $54.17M | +68.2% |
| 2020 | $32.20M | +38.1% |
| 2019 | $23.31M | +178.5% |
| 2018 | $8.37M | +132.7% |
| 2017 | $3.60M | - |